1. Home
  2. THFF vs CGEM Comparison

THFF vs CGEM Comparison

Compare THFF & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THFF
  • CGEM
  • Stock Information
  • Founded
  • THFF 1984
  • CGEM 2016
  • Country
  • THFF United States
  • CGEM United States
  • Employees
  • THFF N/A
  • CGEM N/A
  • Industry
  • THFF Major Banks
  • CGEM Biotechnology: Pharmaceutical Preparations
  • Sector
  • THFF Finance
  • CGEM Health Care
  • Exchange
  • THFF Nasdaq
  • CGEM Nasdaq
  • Market Cap
  • THFF 578.4M
  • CGEM 506.1M
  • IPO Year
  • THFF N/A
  • CGEM 2021
  • Fundamental
  • Price
  • THFF $48.64
  • CGEM $7.50
  • Analyst Decision
  • THFF Buy
  • CGEM Strong Buy
  • Analyst Count
  • THFF 2
  • CGEM 8
  • Target Price
  • THFF $56.50
  • CGEM $32.86
  • AVG Volume (30 Days)
  • THFF 98.3K
  • CGEM 398.2K
  • Earning Date
  • THFF 04-29-2025
  • CGEM 05-14-2025
  • Dividend Yield
  • THFF 4.24%
  • CGEM N/A
  • EPS Growth
  • THFF N/A
  • CGEM N/A
  • EPS
  • THFF 4.00
  • CGEM N/A
  • Revenue
  • THFF $201,592,000.00
  • CGEM N/A
  • Revenue This Year
  • THFF $26.41
  • CGEM N/A
  • Revenue Next Year
  • THFF $2.60
  • CGEM $278.37
  • P/E Ratio
  • THFF $12.24
  • CGEM N/A
  • Revenue Growth
  • THFF N/A
  • CGEM N/A
  • 52 Week Low
  • THFF $34.58
  • CGEM $7.27
  • 52 Week High
  • THFF $53.60
  • CGEM $30.19
  • Technical
  • Relative Strength Index (RSI)
  • THFF 42.45
  • CGEM 31.16
  • Support Level
  • THFF $49.69
  • CGEM $8.01
  • Resistance Level
  • THFF $50.79
  • CGEM $9.16
  • Average True Range (ATR)
  • THFF 1.19
  • CGEM 0.45
  • MACD
  • THFF -0.12
  • CGEM -0.06
  • Stochastic Oscillator
  • THFF 27.22
  • CGEM 10.91

About THFF First Financial Corporation Indiana

First Financial Corp operates as a financial holding company, which is engaged in the provision of financial services in the United States. The company offers a wide variety of financial services including commercial, mortgage, and consumer lending, lease financing, trust account services, depositor services, and insurance services, through its subsidiaries. Its primary source of revenue is derived from loans to customers and investment activities.

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

Share on Social Networks: